| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 08/04/2005 | WO2005070890A2 Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof |
| 08/04/2005 | WO2005070877A1 Diamino alcohols and their use as renin inhibitors |
| 08/04/2005 | WO2005070871A2 Amino alcohol derivatives and their activity as renin inhibitors |
| 08/04/2005 | WO2005054179A3 Hydroxamic acid esters and pharmaceutical use thereof |
| 08/04/2005 | WO2005040355A3 Tao kinase modulators and methods of use |
| 08/04/2005 | WO2005030188A3 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 08/04/2005 | WO2004092135A3 Substituted benzosulphonamide as potentiators of glutamate receptors |
| 08/04/2005 | US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors |
| 08/04/2005 | US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders |
| 08/04/2005 | US20050171189 Purified racemic lasofoxifene and purified lasofoxifene D-tartrate and a mehtod for effective purification of racemic lasofoxifene |
| 08/04/2005 | US20050171181 Histamine-3 receptor modulators |
| 08/04/2005 | US20050171148 Aryl and heteroaryl compounds, compositions, methods of use |
| 08/04/2005 | US20050171147 Sulfonamide derivatives for the treatment of diseases |
| 08/04/2005 | US20050171120 At the 1-position with an alkyl or aryl 1-(4-trifluoromethylphenyl)-2-methoxyethyl sulfonate, deprotecting; coupling methyl 4-trifluoromethylbenzoate with methyl methoxyacetate, hydrolyzing to form 4-trifluoromethyl methoxyacetophenone; 2-methyl-4-trifluoromethylcarbonyl-piperazine; CCR5 antagonists |
| 08/04/2005 | US20050171119 Two-layer tablet of efletirizine (2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid) containing an immediate release layer and a time-release layer for once daily dosage; antihistamine, bronchodilator and antispasmodic agent |
| 08/04/2005 | US20050171115 conditions ameliorated by monoamine reuptake; vasomotor symptoms; 4-[1-(3-chlorophenyl)-2-piperazin-1-ylethyl]tetrahydro-2H-pyran-4-ol; antidepressantp; sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome; nervous system disorders |
| 08/04/2005 | US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors |
| 08/04/2005 | US20050171102 Semicarbazide derivatives for combating thromboembolic diseases |
| 08/04/2005 | US20050171098 MCH antagonists and their use in the treatment of obesity |
| 08/04/2005 | US20050171092 Chemical compounds |
| 08/04/2005 | US20050171079 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders |
| 08/04/2005 | US20050171068 Novel 4-dedimethylaminotetracycline derivatives |
| 08/04/2005 | US20050171061 Phenylsulfanylphenyl and phenyloxyphenyl substituted piperazine compounds; glycine transport inhibitors; for the treatment of psychoses and convulsive disorders: epilepsy, spasticity, and myoclonus |
| 08/04/2005 | CA2554188A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids |
| 08/04/2005 | CA2553840A1 Amino alcohol derivatives and their activity as renin inhibitors |
| 08/04/2005 | CA2553831A1 Diamino alcohols and their use as renin inhibitors |
| 08/04/2005 | CA2553729A1 Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof |
| 08/03/2005 | EP1559717A2 Oxabispidine compounds useful in the treatment of cardiac arrythmias |
| 08/03/2005 | EP1559707A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds |
| 08/03/2005 | EP1559422A1 Receptor function controlling agent |
| 08/03/2005 | EP1558595A1 Piperazinyl and diazapanyl benzamides and benzthioamides |
| 08/03/2005 | EP1558594A2 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 08/03/2005 | EP1558568A1 Nitroaniline-based alkylating agents and their use as prodrugs |
| 08/03/2005 | EP1558567A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 08/03/2005 | EP1558259A2 Il-8 receptor antagonists |
| 08/03/2005 | EP1558253A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 08/03/2005 | CN1649857A Hydroxamic acid derivatives |
| 08/03/2005 | CN1649856A 4-(diarylmethyl)-1-piperazinyl derivatives |
| 08/03/2005 | CN1649826A 5-amino-1-pentene-3-ol substituted derivatives |
| 08/03/2005 | CN1649820A Compounds that modulate PPAR activity and methods for their preparation |
| 08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
| 08/03/2005 | CN1213044C Amine and amide derivatives as ligands for neuropeptide YY5 receptor useful in treatment of obesity and other disorders |
| 08/03/2005 | CN1213040C Serine protese inhibitors |
| 08/03/2005 | CN1213038C Benzophenones as inhibitors of reverse transcriptase |
| 08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 08/03/2005 | CN1213017C Propynyl or diene diaryl compounds |
| 08/02/2005 | US6924388 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 08/02/2005 | US6924374 Modulators of dopamine neurotransmission |
| 08/02/2005 | CA2362339C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/02/2005 | CA2362337C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 08/02/2005 | CA2170020C Retroviral protease inhibiting compounds |
| 08/02/2005 | CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 07/28/2005 | WO2005068448A1 Sulfonamides antagonising n-type calcium channels |
| 07/28/2005 | WO2005068447A1 Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-upatke inhibitors |
| 07/28/2005 | WO2005068446A1 Labeling reagents, labeled analytes, including mixtures thereof, and fragment ions derived therefrom and methods for the analysis thereof |
| 07/28/2005 | WO2005068415A1 Phenylalanine derivative |
| 07/28/2005 | WO2005067644A2 Conjugated small molecules |
| 07/28/2005 | WO2004110388A3 Sigma ligands for neuronal regeneration and functional recovery |
| 07/28/2005 | WO2004060306A3 Anti-inflammatory medicaments |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 07/28/2005 | CA2553289A1 Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-uptake inhibitors |
| 07/28/2005 | CA2551495A1 Conjugated small molecules |
| 07/27/2005 | EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 07/27/2005 | EP1556365A1 Improvement in the storage stability of photoinitiators |
| 07/27/2005 | EP1556335A1 Bis-alkylbenzylamines |
| 07/27/2005 | EP1556029A2 Thiomolybdate analogues and uses thereof |
| 07/27/2005 | EP1283823A4 Novel mmp-2/mmp-9 inhibitors |
| 07/27/2005 | CN1646509A Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 07/27/2005 | CN1646485A Acyl-4-carboxyphenylurea derivatives, method for production and use thereof |
| 07/27/2005 | CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them |
| 07/26/2005 | CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives |
| 07/21/2005 | WO2005066190A1 New risedronate salts |
| 07/21/2005 | WO2005066148A1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 07/21/2005 | WO2005066112A1 Method for the catalytic reduction of amides |
| 07/21/2005 | WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 07/21/2005 | US20050159622 Reacting a primary or secondary amine with of SO3 or a source in the presence of a tert-amine and reacting the sulfamate formed with a phosphorus halide; the product may be reacted with NH3 to form the sulfamide, the NH2 group of which may then be acylated with a N-heterocycl-N-ylbenzoyl derivative |
| 07/21/2005 | US20050159446 of preparing 4-substituted quinoline compounds as intermediates in the manufacture of receptor tyrosine kinase inhibitors and intermediate compounds used in the methods thereof, wherein the 4-substituted quinoline compound has the following general formula (I): |
| 07/21/2005 | US20050159427 N-acylsulfonamide apoptosis promoters |
| 07/21/2005 | US20050159412 hydroxamic acid and N-formyl hydroxylamine compounds which inhibit the activity of the bacterial enzyme known as peptide deformylase |
| 07/21/2005 | US20050159405 Substituted 10-aryl-11h-benzo[b]fluourenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/21/2005 | US20050159402 Polyarylcarboxamides useful as lipid lowering agents |
| 07/21/2005 | CA2552851A1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 07/20/2005 | EP1554261A1 Antibacterial agents |
| 07/20/2005 | EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 07/20/2005 | EP1554241A1 S-(alpha,alpha'-disubstituted-alpha"-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerisations, process and polymers made therefrom |
| 07/20/2005 | EP1268396B1 Diphenyl ether compounds useful in therapy |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642937A Process for making chiral 1, 4-disubstituted piperazines |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642930A Stereoselective alkylation of chiral 2-methyl-4-protected piperazines |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642906A Novel arylamidine derivative or salt thereof |
| 07/20/2005 | CN1642638A Catalysts and method for the production of amines |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |